University of Maryland - Greenebaum Cancer Center — Baltimore, Maryland

University of Maryland - Greenebaum Cancer Center is a clinical research site located in Baltimore, Maryland, United States 21201.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Maryland - Greenebaum Cancer Center has participated in 7 clinical trials with 1 currently active.

Therapeutic areas: Breast Cancer, Brain Metastases, Hepatic Veno-Occlusive Disease.

Sponsors: Marker Therapeutics, Inc., Angiochem Inc, Jazz Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Maryland - Greenebaum Cancer Center?

University of Maryland - Greenebaum Cancer Center has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Maryland - Greenebaum Cancer Center conducted?

University of Maryland - Greenebaum Cancer Center has 7 clinical trials on record, with 1 currently active. Their work covers Breast Cancer, Brain Metastases, Hepatic Veno-Occlusive Disease.

Is University of Maryland - Greenebaum Cancer Center accredited by Crixeo Health?

Yes — University of Maryland - Greenebaum Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about University of Maryland - Greenebaum Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.